AzTrials
AzTrials

Chronic Low-back PainNCT05851118

Locomotion Strategies of Low Back Pain Patients in a Dynamic Environment

An observational study of Chronic Low-back Pain and Walking, run by University of Rennes 2 at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The biomechanical parameters studied in non-specific chronic low back pain patients in a locomotion task have so far focused on straight line walking. Although locomotion is primarily an automated action composed of repetitive patterns allowing movement from one place to another, walkers must respond to the… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Chronic Low-back Pain, Walking
What is being tested?
Quantified analysis of walking during a crossing task between two walkers
How many people
36 participants
Where
1 siteFrance
Study dates
1 Mar 2023to 1 May 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients with non-specific low back pain are recruited as part of their medical follow-up in a medical centre in France.

Who may be able to join

  • Participants strictly meet the same inclusion and non-inclusion criteria as NSCLBP patients, but must not have ongoing chronic pain or a history of significant chronic pain (≥ 4/10 for at least 6 months). They are matched for age and gender. They must not have any pathologies that affect walking or posture. These individuals must be able to perform the studied movements without the appearance of discomfort or exaggerated fatigue.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Agathe Bilhaut, PhD student contact

+33 (0) 632030985

agathe.bilhaut@univ-rennes2.fr

Anne-Hélène Olivier, PhD contact

anne-helene.olivier@univ-rennes2.fr

France1 site, 1 recruiting
  • University of Rennes 2

    Rennes, 35000

    Agathe Bilhaut, PhD student, +33 (0) 632030985, agathe.bilhaut@univ-rennes2.fr

    Anne-Hélène Olivier, PhD, anne-helene.olivier@univ-rennes2.fr

    Recruiting

Other trials in France

About this study

Official title: Collision Avoidance Behavior Between Walkers: Locomotion Strategies of Patients With Chronic Non-Specific Low Back Pain

The biomechanical parameters studied in non-specific chronic low back pain patients in a locomotion task have so far focused on straight line walking. Although locomotion is primarily an automated action composed of repetitive patterns allowing movement from one place to another, walkers must respond to the environmental demands.These modifications show a flexible and adaptive approach to the constraints of the environment. In this study, the investigators are particularly interested in a task of crossing between two pedestrians, which is a standardised task that has shown its interest in the study of perceptual-motor co-ordination. In particular, it allows to study the mutual adaptation of speed and orientation between the two walkers.

Being tested
Quantified analysis of walking during a crossing task between two walkers
Keywords
Low Back Pain, Psychomotor Performance / physiology, Walking / physiology*, Adult, Humans, Motion Perception / physiology*
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quantified analysis of walking during a crossing task between two walkersBehavioural

    Functional test that reproduce a task of daily living.

Study groups in NCT05851118
Study groupRoleWhat they receive
Non-Specific Low Back Pain patientsParticipants must have pain located between the thoracolumbar hinge and the lower gluteal fold, with or without pain in either leg, present for more than 12 weeks, on a daily or almost daily basis (at least 4 days out of 7).
Receives: Behavioral: Quantified analysis of walking during a crossing task between two walkers
Control groupParticipant with no current or past chronic pain
Receives: Behavioral: Quantified analysis of walking during a crossing task between two walkers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Threshold for motion adaptation

    Thresholds of adaptation to movement will be identified by comparing the minimum crossing distance and the minimum predicted distance of crossing at the time the walkers first see each other.

    Measured: Clinical assessment at base line

Secondary outcomes (4)
  1. Walking speed

    Analysis of the walking speed of each walker for the control tests, i.e. where the walker has not encountered another walker.

    Measured: Clinical assessment at base line

  2. Inversion of crossing order

    mpd(t) was assigned according to the final crossing order between two walkers in such a way that allowed for a positive mpd (tcross). In doing so, a positive mpd(tsee) suggests that crossing order was preserved along the entire interaction. Alternatively, a negative mpd (tsee) is the result of an inversion in crossing order between the two walkers.

    Measured: Clinical assessment at base line

  3. Contribution to collision avoidance

    During the interaction period, a cumulative contribution must be made by both walkers to avoid a collision. Analysis of the contribution of each walker (speed and orientation).

    Measured: Clinical assessment at base line

  4. Minimum Predicted Distance

    Minimum Predicted Distance (mpd) represents the theoretical crossing distance between the future positions of the participants, based on a linear extrapolation of their trajectory given their current position and speed at time (t). Any variation in mpd(t) indicates that a movement adaptation to avoid a collision has taken place between two walkers.

    Measured: Clinical assessment at base line

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2023
  2. Study start1 Mar 2023
  3. Primary completion1 May 2024 (estimated)
  4. Study completion1 May 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05851118
Sponsor's protocol ID
PERL2
Status last verified
May 2023
First submitted
28 Apr 2023
Last updated
11 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Low-back Pain and Walking, run by University of Rennes 2 at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Agathe Bilhaut, PhD student (+33 (0) 632030985, agathe.bilhaut@univ-rennes2.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Threshold for motion adaptation (time frame: Clinical assessment at base line). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in